# Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment

> **NCT05894954** · PHASE3 · COMPLETED · sponsor: **Alzheimer's Prevention and Reversal Project, Inc.** · enrollment: 73 (actual)

## Conditions studied

- Mild Cognitive Impairment
- Dementia, Mild

## Interventions

- **DIETARY_SUPPLEMENT:** Precision Medicine Approach
- **COMBINATION_PRODUCT:** Hormones and Medications tailored to lab tests, combined with devices that support stress management and brain exercises
- **BEHAVIORAL:** Standard-of-Care
- **BEHAVIORAL:** Lifestyle including diet, exercise, stress management

## Key facts

- **NCT ID:** NCT05894954
- **Lead sponsor:** Alzheimer's Prevention and Reversal Project, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-31
- **Primary completion:** 2025-10-31
- **Final completion:** 2026-02-09
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2026-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05894954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05894954, "Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05894954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*